US Broker Ratings

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A 44.59% Upside Amid Strong Buy Ratings

Travere Therapeutics, Inc. (NASDAQ: TVTX) stands out in the biotechnology sector with a robust market capitalization of $4.84 billion. Based in San Diego, California, the company..

Opko Health, Inc. (OPK) Stock Analysis: Unpacking a Potential 217% Upside for Investors

Opko Health, Inc. (NASDAQ: OPK) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Miami, Florida, the company..

Mineralys Therapeutics, Inc. (MLYS): Investor Outlook on a Potential 108% Upside

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is capturing the attention of investors with its promising pipeline and significant potential upside. As a biotechnology firm headquartered in Radnor,..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 29% Potential Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands as a noteworthy player within the Healthcare sector, specifically in the Medical Instruments & Supplies industry. Based in Burlington, Massachusetts,..

Teladoc Health, Inc. (TDOC) Investor Outlook: Analyzing the 28% Upside Potential

Teladoc Health, Inc. (NYSE: TDOC) has captured the attention of investors with its transformative approach to healthcare. As a leading provider of virtual healthcare services, the..

Integra LifeSciences Holdings C (IART) Stock Analysis: Exploring a Potential 31% Upside Amidst Industry Challenges

Integra LifeSciences Holdings Corporation (NASDAQ: IART) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Princeton, New Jersey,..

BGM Group Ltd. (BGM): Navigating Uncharted Waters in Healthcare with a 69.80% Revenue Surge

BGM Group Ltd. (BGM), a dynamic player in China’s healthcare sector, is making significant waves with a remarkable revenue growth of 69.80%. Operating in the specialty..

Wave Life Sciences, Inc. (WVE) Stock Analysis: Unveiling a 450% Potential Upside in the Biotech Arena

Wave Life Sciences, Inc. (NASDAQ: WVE), a trailblazer in the biotechnology sector, is making waves with its ambitious RNA medicines platform, PRISM. Headquartered in Cambridge, Massachusetts,..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Navigating the 79.97% Potential Upside in the Biotech Sector

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is a clinical-stage biotechnology company that has captured the attention of investors with its innovative approach to drug discovery. Leveraging cutting-edge..

Stock Analysis: BioLife Solutions, Inc. (BLFS) Faces a Challenging -19.71% Potential Downside

BioLife Solutions, Inc. (BLFS), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is facing a challenging investment landscape. With..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 12.88% Potential Upside with Strong Buy Ratings

U.S. Physical Therapy, Inc. (NYSE: USPH) is a compelling player within the healthcare sector, specifically in the medical care facilities industry, offering a notable opportunity for..

LivaNova PLC (LIVN) Stock Analysis: Healthcare Innovator Set for a 17% Upside

LivaNova PLC (NASDAQ: LIVN), a leading name in the medical devices industry, stands at an intriguing juncture for investors, boasting a potential upside of 17.18% according..

Arrowhead Pharmaceuticals (ARWR): Growth Potential with a 76.57% Upside Sparks Investor Interest

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, is gaining attention from investors, particularly due to its significant growth potential amid a..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Potential 438% Upside Amid Biotech Innovation

Investors with an eye for biotechnology innovation should keep ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) on their radar. This San Diego-based biotech firm is pioneering the development..

Aurinia Pharmaceuticals Inc (AUPH) Investor Outlook: Analyzing the 7.9% Potential Upside

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) has emerged as a compelling opportunity within the biotechnology sector, particularly for investors keen on capitalizing on advancements in treatments for..

Vericel Corporation (VCEL) Stock Analysis: With a 49% Potential Upside, Is Now the Time to Buy?

Investors with an eye on the healthcare sector, particularly within biotechnology, may find Vericel Corporation (NASDAQ: VCEL) an intriguing opportunity. With a market capitalization of $2.08..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: A 147.93% Upside Opportunity in the Biotech Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a biotechnology company headquartered in Durham, North Carolina, is making waves in the healthcare sector with its innovative approach to treating..

Immunocore Holdings plc (IMCR): Investor Outlook Reveals a Promising 116% Upside Potential

Immunocore Holdings plc (NASDAQ: IMCR) is capturing investor attention with a remarkable potential upside of 116%, according to analysts’ forecasts. With its innovative approach in the..

Ocular Therapeutix, Inc. (OCUL) Investor Outlook: Biotech Stock Offers 243.92% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing the attention of the investment community with its compelling potential upside of 243.92%. As a biopharmaceutical company pioneering in..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a Potential 133% Upside

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a notable player in the biotechnology sector, is making waves in the healthcare industry with its innovative approach to treating..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds